BALYASNY ASSET MANAGEMENT L.P. - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 90 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$23,000
+15.0%
29,524
+89.3%
0.00%
Q4 2021$20,000
-85.7%
15,597
-54.5%
0.00%
-100.0%
Q3 2020$140,000
-84.6%
34,252
-67.6%
0.00%
-83.3%
Q2 2019$909,000
+64.4%
105,556
+104.1%
0.01%
+50.0%
Q1 2019$553,000
-79.6%
51,714
-83.3%
0.00%
-80.0%
Q4 2018$2,708,000
+162.1%
309,497
+519.0%
0.02%
+300.0%
Q3 2018$1,033,000
-85.3%
50,000
-85.1%
0.01%
-84.4%
Q2 2018$7,022,000
+13.8%
335,028
-12.6%
0.03%
+23.1%
Q1 2018$6,169,000
-42.0%
383,423
-31.6%
0.03%
-21.2%
Q4 2017$10,629,000
+13885.5%
560,918
+4348.9%
0.03%
+3200.0%
Q4 2015$76,000
-97.6%
12,608
-96.6%
0.00%
-97.6%
Q3 2013$3,129,000
+179.6%
373,336
+148.9%
0.04%
+121.1%
Q2 2013$1,119,000150,0000.02%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Piermont Capital Management Inc. 312,842$2,033,0000.48%
BARD ASSOCIATES INC 648,525$4,215,0000.39%
Sonora Investment Management, LLC 233,295$1,516,418,0000.30%
Nine Chapters Capital Management LLC 32,400$211,0000.28%
Alambic Investment Management, L.P. 287,601$1,869,0000.23%
Granite Investment Partners, LLC 201,221$1,308,0000.09%
Renaissance Technologies 5,679,800$36,919,0000.05%
PDT Partners, LLC 123,200$801,0000.04%
ClariVest Asset Management LLC 242,050$1,573,0000.04%
KENNEDY CAPITAL MANAGEMENT LLC 315,934$2,054,0000.04%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders